Routine full blood counts as indicators of acute viral infections.

Por Nixon, D F, Parsons, A J, Eglin, R P
Publicado em 1987

Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes.

Por Waterfield, J D, Nixon, D F, Mair, M G
Publicado em 1981

Cellular and humoral antigenic epitopes in HIV and SIV.

Por Nixon, D F, Broliden, K, Ogg, G, Broliden, P A
Publicado em 1992

Rational Peptide Selection To Detect Human Immunodeficiency Virus Type 1-Specific T-Cell Responses under Resource-Limited Conditions

Por Willberg, C. B., Pillai, S. K., Sharp, E. R., Rosenberg, M. G., Agudelo, J. D., Barbour, J. D., Nixon, D. F.
Publicado em 2007

Potentially Exposed but Uninfected Individuals Produce Cytotoxic and Polyfunctional Human Immunodeficiency Virus Type 1-Specific CD8(+) T-Cell Responses Which Can Be Defined to the...

Por Erickson, A. L., Willberg, C. B., McMahan, V., Liu, A., Buchbinder, S. P., Grohskopf, L. A., Grant, R. M., Nixon, D. F.
Publicado em 2008

Why do cytotoxic T lymphocytes fail to eliminate hepatitis C virus? Lessons from studies using major histocompatibility complex class I peptide tetramers.

Por Lechner, F, Sullivan, J, Spiegel, H, Nixon, D F, Ferrari, B, Davis, A, Borkowsky, B, Pollack, H, Barnes, E, Dusheiko, G, Klenerman, P
Publicado em 2000

Antiretroviral Drug Therapy Alters the Profile of Human Immunodeficiency Virus Type 1-Specific T-Cell Responses and Shifts the Immunodominant Cytotoxic T-Lymphocyte Response from G...

Por Karlsson, A. C., Chapman, J. M., Heiken, B. D., Hoh, R., Kallas, E. G., Martin, J. N., Hecht, F. M., Deeks, S. G., Nixon, D. F.
Publicado em 2007

Direct Ex Vivo Measurement of CD8(+) T-Lymphocyte Responses to Human Parvovirus B19

Por Tolfvenstam, T., Oxenius, A., Price, D. A., Shacklett, B. L., Spiegel, H. M. L., Hedman, K., Norbeck, O., Levi, M., Olsen, K., Kantzanou, M., Nixon, D. F., Broliden, K., Klenerman, P.
Publicado em 2001

Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy

Por Ogg, G. S., Jin, X., Bonhoeffer, S., Moss, P., Nowak, M. A., Monard, S., Segal, J. P., Cao, Y., Rowland-Jones, S. L., Hurley, A., Markowitz, M., Ho, D. D., McMichael, A. J., Nixon, D. F.
Publicado em 1999

Skewed Distribution of Natural Killer Cells in Psoriasis Skin Lesions

Por Batista, M. D., Ho, E. L., Kuebler, P. J., Milush, J. M., Lanier, L. L., Kallas, E. G., York, V. A., Chang, D., Liao, W., Unemori, P., Leslie, K. S., Maurer, T., Nixon, D. F.
Publicado em 2013

Antiviral gene expression in psoriasis

Por Raposo, R.A., Gupta, R., Abdel-Mohsen, M., Dimon, M., Debbaneh, M., Jiang, W., York, V.A., Leadabrand, K.S., Brown, G., Malakouti, M., Arron, S., Kuebler, P.J., Wu, J.J., Pillai, S.K., Nixon, D.F., Liao, W.
Publicado no J Eur Acad Dermatol Venereol (2015)

Lower numbers of circulating natural killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease

Por Ndhlovu, L C, Snyder-Cappione, J E, Carvalho, K I, Leal, F E, Loo, C P, bruno, F R, Jha, A R, Devita, D, Hasenkrug, A M, Barbosa, H M R, Segurado, A C, Nixon, D F, Murphy, E L, Kallas, E G
Publicado em 2009